Dr. Kavita Mariwalla, a Board Certified Dermatologist and a paid spokesperson for Aclaris Therapeutics & ESKATA joins eHealth Radio and the Dermatology and Health News Channels to talk about the impact of seborrheic keratoses and a new treatment for patients.
- What are seborrheic keratoses (SKs) and how do people get them?
- What is ESKATA® 40 % hydrogen peroxide topical solution, and how is it used?
- What other treatments are available to address SKs?
- What did the clinical studies of ESKATA® 40 % hydrogen peroxide topical solution show? What are the benefits and potential side effects?
- Why is this new treatment important for your patients?
Dr. Kavita Mariwalla is a nationally recognized leader in dermatology and dermatologic surgery, whose expertise is in the areas of anti-aging procedures and skin cancer treatment.
Prior to starting her own private practice, Dr. Mariwalla was the Director of Cutaneous Oncology at St. Luke’s – Roosevelt and Beth Israel Medical Centers in New York. Dr. Mariwalla has been recognized for extensive work in the area of dermatologic education and is considered an expert injector of fillers and neuromodulators. She has written two editions of the widely used book, “Primer in Dermatologic Surgery,” which is highly regarded by residents and seasoned dermatologic surgeons and is author of the “Cosmeceutical Compendium.” Dr. Mariwalla is editor of “Surgical Pearls” for the Journal of the American Academy of Dermatology and sits on the Board of Directors of the Women’s Dermatologic Society and American Society for Dermatologic Surgery.
In addition, Dr. Mariwalla is noted for sharing her injection techniques during live demonstrations at the American Academy of Dermatology annual meetings. Her private practice has been nominated for the “Best of Long Island,” since its inception in 2012.
Dr. Mariwalla earned her degree in medicine at the Yale School of Medicine where she also completed her dermatology residency and fellowship training.